DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Editorial: Community series in mouse models of B cell malignancies, volume II
B-cell malignancies are a diverse group of cancers that originate from B lymphocytes at different developmental and differentiation stages exhibiting distinctive progression patterns and symptoms. Prognosis depends on the histological type, disease stage, and available treatment (reviewed in (1–3). In the last decades, advances in medical research have significantly improved the outcomes for these patients. However, a deeper knowledge on the origin, progression, and development of refractoriness and relapse is needed for providing patients with new treatments with better remission rates or longer progression-free survival. In addition, tools allowing a more accurate preclinical prediction on how new therapeutic approaches would work in clinics are also needed., GP-C and JMZ were supported by a grant from the Agencia Estatal de Investigacion (PID2022-136909OB-I00). CV-F was supported by the International Waldenström Macroglobulinemia Fundation, the “Fondation ARC pour la recherche sur la cancer” and the “Ligue contre le cancer comités Haute-Vienne et Creuse”., Peer reviewed